capecitabine has been researched along with Cancer of Cervix in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eda, H; Endoh, M; Hattori, K; Horii, I; Ishikawa, T; Ishitsuka, H; Kawashima, A; Kohchi, Y; Miwa, M; Oikawa, N; Shimma, N; Suda, H; Tanimura, H; Ura, M | 1 |
| Bydder, G; Bydder, M; Carmona, R; Gulaya, S; Mell, LK; Pritz, J; Vaida, F; Welch, CS; Williamson, CW; Zhu, H | 1 |
| Baranov, SB; Berlev, IV; Guseĭnov, KD; Maksimov, SIa; Mikaia, NA; Urmancheeva, AF | 1 |
| Autorino, R; Fagotti, A; Fanfani, F; Ferrandina, G; Foti, E; Gallotta, V; Gambacorta, A; Scambia, G; Smaniotto, D; Tagliaferri, L; Valentini, V | 1 |
| Cupino, N; de Los Reyes, R; Domingo, E; Jin, K; Kamnerdsupaphon, P; Lertbutsayanukul, C; Lertsanguansinchai, P; Lorvidhaya, V; Syortin, T; Tharavichitkul, E; Vito-Cruz, E; Yoshihara, M | 1 |
| Chitapanarux, I; Hsieh, CY; Kamnerdsupaphon, P; Lertsanguansinchai, P; Lorvidhaya, V; Phromratanapongse, P; Sukthomya, V; Tharavichitkul, E | 1 |
| Elghissassi, I; Errihani, H; Inrhaoun, H; Ismaili, N; M'rabti, H | 1 |
| Hasegawa, K; Kato, R; Kawamura, K; Kobayashi, Y; Okamoto, H; Sekiya, T; Udagawa, Y | 1 |
| Atkinson, EN; Bodurka, DC; Brown, J; Jenkins, AD; Johnston, T; Levenback, C; Ramondetta, LM; Sun, C; Wolf, JK | 1 |
| Chan, S; Curto, J; Habeshaw, T; Joynson, C; Reed, N; Stokes, Z; Symonds, P | 1 |
| Gibb, RK; Grigsby, PW; Mutch, DG; Powell, MA; Rader, JS; Viviano, D; Wright, JD | 1 |
| Chan, S; Dhadda, AS | 1 |
| Blessing, JA; Darcy, KM; Garcia, AA; Hannigan, E; Lenz, HJ; Moore, DH; Zhang, W | 1 |
| Benjapibal, M; Inthasorn, P; Leelaphatanadit, C; Therasakvichya, S; Thirapakawong, C | 1 |
8 trial(s) available for capecitabine and Cancer of Cervix
| Article | Year |
|---|---|
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Deoxycytidine; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Fluorouracil; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Pelvis; Prospective Studies; Radiotherapy, Conformal; Survival; Uterine Cervical Neoplasms | 2014 |
Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brachytherapy; Capecitabine; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Middle Aged; Survival Rate; Uterine Cervical Neoplasms | 2009 |
Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms | 2010 |
Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Agents; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 2011 |
Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Uterine Cervical Neoplasms | 2005 |
Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Hematologic Diseases; Humans; Middle Aged; Radiotherapy; Uterine Cervical Neoplasms | 2005 |
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Protein Biosynthesis; Thymidine Phosphorylase; Thymidylate Synthase; Uterine Cervical Neoplasms | 2007 |
A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Cisplatin; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 2007 |
6 other study(ies) available for capecitabine and Cancer of Cervix
| Article | Year |
|---|---|
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Non-Small-Cell Lung; Cytidine Deaminase; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Design; Drug Stability; Esterases; Female; Fluorouracil; Humans; Lung Neoplasms; Mice; Oxidoreductases; Prodrugs; Thymidine Phosphorylase; Tissue Distribution; Uracil; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2003 |
Fat composition changes in bone marrow during chemotherapy and radiation therapy.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Capecitabine; Cervical Vertebrae; Cetuximab; Chemoradiotherapy; Cisplatin; Deoxycytidine; Endometrial Neoplasms; Female; Fluorouracil; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Paclitaxel; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Spine; Thoracic Vertebrae; Uterine Cervical Neoplasms | 2014 |
[Neoadjuvant chemoradiotherapy in the combined treatment of patients with stage IB2-III cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Russia; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2014 |
The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Female; Floxuridine; Fluorouracil; Humans; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Peplomycin; Thymidine Phosphorylase; Uterine Cervical Neoplasms | 2012 |
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Retrospective Studies; Uterine Cervical Neoplasms | 2006 |
Bilateral avascular necrosis of the hips after chemoradiotherapy for cervical cancer.
Topics: Adult; Antineoplastic Agents; Capecitabine; Cisplatin; Deoxycytidine; Female; Femur Head Necrosis; Fluorouracil; Humans; Uterine Cervical Neoplasms; X-Rays | 2006 |